Connect with us

National

When a SARS-CoV-2 vaccine arrives, who should be vaccinated first? – News-Medical.Net

This new study by the researchers at Fred Hutchinson Cancer Research Center and the University of Washington, Tacoma and published on the preprint server medRxiv in August 2020 describes one viewpoint concerning the optimized allocation of the vaccine, showin…

Published

on

One of the most intensively researched areas today is the creation of an effective universal vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). An effective SARS-CoV-2 vaccine is the best single tool to help the world revert to a more normal situation by extinguishing viral spread without the need for lockdowns and travel restrictions. However, even when a vaccine becomes available, there is likely to be a resource bottleneck, keeping in view the massive need for t…

Click here to view the original article.